Clorox Co
CLX: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$248.00 | Nvpw | Sznvlgxfk |
Clorox’s Efforts To Rebuild Margins Not Poised To Come at the Expense of Crucial Brand Spending
Business Strategy and Outlook
While volume growth has been hard to come by since the pandemic prompted consumers to scour the shelves for Clorox’s fare, we don’t think consumers are turning their backs on Clorox’s cleaning and disinfecting products, as overall sales remain well above where they were before the pandemic (to the tune of 20% in its fiscal third quarter). This prowess is further evidenced by its disinfecting wipes offering, which has been gaining market share.